Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EF-hand domain-containing protein 1 (EFHC1) is an evolutionarily conserved protein characterized by the presence of EF-hand calcium-binding motifs and is required for proper function of cilia—organelle structures protruding from cells involved in sensing and signaling[1][2]. EFHC1 localizes to motile and non-motile cilia as well as to presynaptic regions of neurons, where it is involved in regulating neuronal excitability, mechanosensory processing, and dopamine neurotransmission[1][2]. In humans, mutations in the EFHC1 gene represent one of the most frequent identifiable causes of juvenile myoclonic epilepsy, a common idiopathic epilepsy syndrome[1][2]. EFHC1 is not a receptor or classical drug target, but its pivotal role in ciliary signaling and synaptic function explains its importance in neurodevelopment and disease, particularly in epilepsy through altered neuronal signal thresholds and neurotransmitter regulation[1][2].
Not a direct drug target; mutations cause loss-of-function influencing cilia and neuronal signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on EF-hand domain-containing protein 1 (EFHC1).